New From Sfanos Lab: Composition of Gastrointestinal Microbiota in Association with Treatment Rresponse in Individuals with Metastatic Castrate Resistant Prostate Cancer Progressing on Enzalutamide and Initiating Treatment with anti-PD-1 (pembrolizumab)

Check out our new study that characterized the gastrointestinal microbiota as individuals with metastatic CRPC who are progressing on enzalutamide initiate treatment with pembrolizumab. The study, headed by former Sfanos Lab graduate student Dr. Lauren Peiffer was recently published in Neoplasia. Congratulations Lauren!

Posted in News.

Leave a Reply